Why Being NICE is Deadly

  • by: |
  • 01/20/2009
A study published today in the Annals of Internal Medicine deemed the use of warfarin gene testing prior to warfarin treatment as not cost-effective because the researchers said at $170K per one life year free of serious bleed for a $400 test was about $120K too much.  $50K is of course the "benchmark" produced out of thin air in 1985 for the value of dialysis for a 65 year old person. 

Now some facts for the likely consumer:

About seven percent of all patients who take the drug warfarin to prevent blood clots in the legs will have a major bleeding episode within one year of treatment, according to researchers who analyzed 33 studies covering 10,757 patients. About one in eight will die, 10% will bleed inside the brain, and half of these patients with an intracranial bleed will die.

Now let's administer the drugwonks comparative effectiveness test to the authors of the study:  Knowing this and assuming that a family member had to take warfarin to prevent blood clots, would you refuse to pay for a genetic test or give an AHIP thumbs up to denying coverage on the grounds that at $400 a pop, society and you are better off taking the risk of intercranial bleeding and death.  And that's just the leg mind you.   We haven't even gotten to other warfarin uses.

I thought we were all concerned about safety.
CMPI

Center for Medicine in the Public Interest is a nonprofit, non-partisan organization promoting innovative solutions that advance medical progress, reduce health disparities, extend life and make health care more affordable, preventive and patient-centered. CMPI also provides the public, policymakers and the media a reliable source of independent scientific analysis on issues ranging from personalized medicine, food and drug safety, health care reform and comparative effectiveness.

Blog Roll

Alliance for Patient Access Alternative Health Practice
AHRP
Better Health
BigGovHealth
Biotech Blog
BrandweekNRX
CA Medicine man
Cafe Pharma
Campaign for Modern Medicines
Carlat Psychiatry Blog
Clinical Psychology and Psychiatry: A Closer Look
Conservative's Forum
Club For Growth
CNEhealth.org
Diabetes Mine
Disruptive Women
Doctors For Patient Care
Dr. Gov
Drug Channels
DTC Perspectives
eDrugSearch
Envisioning 2.0
EyeOnFDA
FDA Law Blog
Fierce Pharma
fightingdiseases.org
Fresh Air Fund
Furious Seasons
Gooznews
Gel Health News
Hands Off My Health
Health Business Blog
Health Care BS
Health Care for All
Healthy Skepticism
Hooked: Ethics, Medicine, and Pharma
Hugh Hewitt
IgniteBlog
In the Pipeline
In Vivo
Instapundit
Internet Drug News
Jaz'd Healthcare
Jaz'd Pharmaceutical Industry
Jim Edwards' NRx
Kaus Files
KevinMD
Laffer Health Care Report
Little Green Footballs
Med Buzz
Media Research Center
Medrants
More than Medicine
National Review
Neuroethics & Law
Newsbusters
Nurses For Reform
Nurses For Reform Blog
Opinion Journal
Orange Book
PAL
Peter Rost
Pharm Aid
Pharma Blog Review
Pharma Blogsphere
Pharma Marketing Blog
Pharmablogger
Pharmacology Corner
Pharmagossip
Pharmamotion
Pharmalot
Pharmaceutical Business Review
Piper Report
Polipundit
Powerline
Prescription for a Cure
Public Plan Facts
Quackwatch
Real Clear Politics
Remedyhealthcare
Shark Report
Shearlings Got Plowed
StateHouseCall.org
Taking Back America
Terra Sigillata
The Cycle
The Catalyst
The Lonely Conservative
TortsProf
Town Hall
Washington Monthly
World of DTC Marketing
WSJ Health Blog